Actress Eva Noblezada talks about her personal journey in theater. Plus, a new romance book does its own spin on Shakespeare. And, public art at a local university.
Marlene (Haas) Kolling was born on May 29, 1942, to Joseph and Eva Haas. She was the 6th of 8 children born into the family. She grew up and attended school in Lefor, ND where her family had a farm. Marlene loved reading and going to dances. She met and married the love of her life, George F. Kolling, who was from Dickinson, ND. They were married on July 12, 1961, while George was in the Air Force. George and Marlene had raised three children; George who they called, Butch, Laurie and Neil. Their eldest son, Butch was born in Rapid City, SD while George was in the Air Force; Laurie and Neil were born in Dickinson, where they resided after George got out of the service. The family moved to Glendive, MT in 1975. In 1976, Marlene started work at the Burlington Northern Credit Union and was eventually the Manager of the Credit Union until she retired in 2004. After retiring, she and George moved to Bismarck, to be closer to Laurie and her children.
STORM to deliver small molecule ADAR1 clinical candidate compounds discovered using its proprietary RNA modifying enzyme drug discovery platform - Exelixis, Inc. (Nasdaq: EXEL) and STORM Therapeutics
Published: Apr 23, 2021
LONDON and RALEIGH, N.C., April 23, 2021 (GLOBE NEWSWIRE)
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces data from a pilot study of a pressurized metered-dose inhaler (“pMDI”) formulation of ensifentrine showed that ensifentrine was safe and well tolerated in patients infected with SARS-CoV-2, the virus that causes COVID-19. The trial was not designed or sized to demonstrate clinical efficacy and no clinical efficacy benefit with ensifentrine treatment added on to standard of care was observed in the trial. One patient death was reported in the ensifentrine treatment group.
“Overall, the patients in this study recovered exceptionally well, as the mortality rate in the study was much lower than aggregate data from the hospital would have suggested over the same time period,” commented Mike Wells, MD, a pulmonologist and Principal Investigator at the
Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U S Patients Hospitalized with COVID-19 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.